BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21659619)

  • 1. Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.
    Hodges CA; Grady BR; Mishra K; Cotton CU; Drumm ML
    Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G528-36. PubMed ID: 21659619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth deficits in cystic fibrosis mice begin in utero prior to IGF-1 reduction.
    Darrah R; Bederman I; Vitko M; Valerio DM; Drumm ML; Hodges CA
    PLoS One; 2017; 12(4):e0175467. PubMed ID: 28384265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal bicarbonate secretion in cystic fibrosis mice.
    Clarke LL; Stien X; Walker NM
    JOP; 2001 Jul; 2(4 Suppl):263-7. PubMed ID: 11875269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
    Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
    Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
    Young SM; Woode RA; Williams EC; Ericsson AC; Clarke LL
    Physiol Genomics; 2024 Mar; 56(3):247-264. PubMed ID: 38073491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cystic fibrosis intestine.
    De Lisle RC; Borowitz D
    Cold Spring Harb Perspect Med; 2013 Sep; 3(9):a009753. PubMed ID: 23788646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute TGFβ expression drives inflammation, goblet cell hyperplasia, and pulmonary function abnormalities in mice with effects dependent on CFTR function.
    Kramer EL; Hardie WD; Madala SK; Davidson C; Clancy JP
    Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L456-L465. PubMed ID: 29877096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective CFTR promotes intestinal proliferation via inhibition of the hedgehog pathway during cystic fibrosis.
    Liu K; Wang X; Zou C; Zhang J; Chen H; Tsang L; Yu MK; Chung YW; Wang J; Dai Y; Liu Y; Zhang X
    Cancer Lett; 2019 Apr; 446():15-24. PubMed ID: 30639531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in MSRA modifies risk of neonatal intestinal obstruction in cystic fibrosis.
    Henderson LB; Doshi VK; Blackman SM; Naughton KM; Pace RG; Moskovitz J; Knowles MR; Durie PR; Drumm ML; Cutting GR
    PLoS Genet; 2012; 8(3):e1002580. PubMed ID: 22438829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous rescue from cystic fibrosis in a mouse model.
    Charizopoulou N; Wilke M; Dorsch M; Bot A; Jorna H; Jansen S; Stanke F; Hedrich HJ; de Jonge HR; Tümmler B
    BMC Genet; 2006 Mar; 7():18. PubMed ID: 16571105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice.
    Canale-Zambrano JC; Auger ML; Haston CK
    Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G381-90. PubMed ID: 20522639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
    Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
    PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene.
    Du M; Jones JR; Lanier J; Keeling KM; Lindsey JR; Tousson A; Bebök Z; Whitsett JA; Dey CR; Colledge WH; Evans MJ; Sorscher EJ; Bedwell DM
    J Mol Med (Berl); 2002 Sep; 80(9):595-604. PubMed ID: 12226741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis.
    Blackman SM; Deering-Brose R; McWilliams R; Naughton K; Coleman B; Lai T; Algire M; Beck S; Hoover-Fong J; Hamosh A; Fallin MD; West K; Arking DE; Chakravarti A; Cutler DJ; Cutting GR
    Gastroenterology; 2006 Oct; 131(4):1030-9. PubMed ID: 17030173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse as a model of growth retardation in cystic fibrosis.
    Rosenberg LA; Schluchter MD; Parlow AF; Drumm ML
    Pediatr Res; 2006 Feb; 59(2):191-5. PubMed ID: 16439577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic Fibrosis and the Nervous System.
    Reznikov LR
    Chest; 2017 May; 151(5):1147-1155. PubMed ID: 27876591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Goblet cell hyperplasia is not epithelial-autonomous in the Cftr knockout intestine.
    Walker NM; Liu J; Young SM; Woode RA; Clarke LL
    Am J Physiol Gastrointest Liver Physiol; 2022 Feb; 322(2):G282-G293. PubMed ID: 34878935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of cystic fibrosis intestinal mucous disease in mice by restoration of mCLCA3.
    Young FD; Newbigging S; Choi C; Keet M; Kent G; Rozmahel RF
    Gastroenterology; 2007 Dec; 133(6):1928-37. PubMed ID: 18054564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo measurements of ion transport in long-living CF mice.
    Wilschanski MA; Rozmahel R; Beharry S; Kent G; Li C; Tsui LC; Durie P; Bear CE
    Biochem Biophys Res Commun; 1996 Feb; 219(3):753-9. PubMed ID: 8645253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sheep model of cystic fibrosis generated by CRISPR/Cas9 disruption of the CFTR gene.
    Fan Z; Perisse IV; Cotton CU; Regouski M; Meng Q; Domb C; Van Wettere AJ; Wang Z; Harris A; White KL; Polejaeva IA
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.